Therapeutic potential of purpurin, a natural anthraquinone dye, in neuroprotection and neurological disorders
Inflammopharmacology · 2025-11 · 33 (11) · 6377-6388
DOI: 10.1007/s10787-025-01977-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammopharmacology, online erschienen am 04.10.2025. Verfasst von Aya M Mustafa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Egyptian Russian University, Badr City, 11829, Cairo, Egypt. Hauptthemen laut MEDLINE: Anthraquinones, Neuroprotective Agents, Nervous System Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Egyptian Russian University.
Abstract (Originalsprache)
Purpurin (1,2,4-trihydroxy-9,10-anthraquinone) is a naturally occurring anthraquinone pigment derived primarily from Rubia species. Beyond its traditional use as a natural dye, purpurin has recently gained attention for its multifaceted pharmacological activities, particularly in neuroprotection. This review outlines the biosynthetic pathways leading to anthraquinone formation via the shikimate, mevalonate, and methylerythritol phosphate routes, culminating in the generation of purpurin. Structure–activity relationship analyses highlight the critical role of hydroxyl substitutions in modulating antioxidant, anticancer, antibacterial, and neuroprotective properties through radical stabilization, DNA intercalation, and metal chelation. Evidence from preclinical studies indicates that purpurin exerts beneficial effects in Alzheimer’s disease, depression, ischemic stroke, and age-related cognitive decline, primarily through anti-tau aggregation, cholinesterase inhibition, serotonergic modulation, antioxidant activity, and anti-inflammatory mechanisms. While purpurin exhibits low acute toxicity and promising pharmacodynamics, its therapeutic translation remains limited by poor solubility, rapid metabolism, and low brain bioavailability. Nanotechnology-based formulations and molecular modifications are being explored to overcome these challenges. Collectively, purpurin represents a versatile bioactive scaffold with considerable potential for the development of multifunctional neuroprotective agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Egyptian Russian University, Badr City, 11829, Cairo, Egypt.
- Biochemistry Department, Faculty of Pharmacy, Egyptian Russian University in Cairo, Badr City, 11829, Cairo, Egypt. ghadir-ali@eru.edu.eg.
- Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Future University in Egypt, Cairo, Egypt. shaimaa.hatem@fue.edu.eg.
- Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
- Department of Pharmacognosy, Faculty of Pharmacy, Suez Canal University, Ismailia, 41522, Egypt.
- Department of Pharmacognosy, Faculty of Pharmacy, Egyptian Russian University, Cairo-Suez Road, Badr City, 11829, Cairo, Egypt.
Förderung
- Egyptian Russian University
Zitieren
APA
Mustafa, A. M., Sayed, G. A., Hatem, S., Moussa, R. A., Hal, D. M., Mansour, M. A., & Abd El Hafeez, M. S. (2025). Therapeutic potential of purpurin, a natural anthraquinone dye, in neuroprotection and neurological disorders. Inflammopharmacology, 33(11), 6377-6388. https://doi.org/10.1007/s10787-025-01977-7
Vancouver
Mustafa AM, Sayed GA, Hatem S, Moussa RA, Hal DM, Mansour MA, et al. Therapeutic potential of purpurin, a natural anthraquinone dye, in neuroprotection and neurological disorders. Inflammopharmacology. 2025;33(11):6377-6388. doi:10.1007/s10787-025-01977-7
BibTeX
@article{Mustafa2025,
author = {Mustafa, Aya M and Sayed, Ghadir A and Hatem, Shymaa and Moussa, Roxane Abdel-Gawad and Hal, Dina M and Mansour, Mahmoud A and Abd El Hafeez, Mohamed S},
title = {Therapeutic potential of purpurin, a natural anthraquinone dye, in neuroprotection and neurological disorders},
journal = {Inflammopharmacology},
year = {2025},
volume = {33},
number = {11},
pages = {6377--6388},
doi = {10.1007/s10787-025-01977-7}
}
EUVIMED